Myriad Genetics focuses on advanced genetic testing technologies that enable personalized medicine and improve patient outcomes. The company specializes in molecular diagnostics, utilizing next-generation sequencing (NGS) to analyze genetic variations associated with various diseases, particularly cancer. Their proprietary tests assess hereditary cancer risk, guide treatment decisions, and monitor therapeutic responses, thereby empowering healthcare providers and patients with critical information for informed decision-making.

In addition to cancer diagnostics, Myriad Genetics is expanding its portfolio to include tests for other conditions, such as cardiovascular diseases and neurodegenerative disorders. The company employs bioinformatics and data analytics to interpret complex genetic data, ensuring accurate results and actionable insights. By integrating cutting-edge technologies with a deep understanding of genetics, Myriad Genetics aims to enhance the precision of healthcare and contribute to the advancement of personalized treatment strategies.

Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers molecular tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care and lower healthcare costs.

Myriad Genetics

Myriad Genetics

Company Details